Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-006327

Chief Operating Officer sold 23,684 shares at an average $8.59 ($203,487)

  • Chief Operating Officer acquired 88,652 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ADAMS R MARK · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-06 Grant or award : show line 1 in the form +88,652 202,170 D
2023-03-06 Sale : show line 2 in the form −6,529 $8.57 $55,954 195,641 D
2023-03-07 Sale : show line 3 in the form −17,155 $8.60 $147,533 178,486 D
Open-market sales · 23,684 sh · avg $8.59 · $203,487

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-06 Grant or award : show line 4 in the form Stock Option (right to buy) +133,033 133,033 D
Loading xslF345X03/form4.xml…